Login to Your Account



Ikaria, BioLineRx Enter Cardiac Licensing Deal Worth $282.5M

By Catherine Hollingsworth


Tuesday, July 7, 2009
Ikaria Holdings Inc. has entered a deal worth a potential $282.5 million with Jerusalem-based BioLineRx Ltd. to license a cardiac remodeling product. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription